Whether you plan on producing cosmetics or personal care products, when operating in the field of skin care, product testing is a necessary part of the process.
CPT℠ is committed to both our clients and their consumers. By performing clinical trials, a repeated insult patch test can help determine any potential irritation or sensitization issues, minimizing the risk of potential reactions for the consumer and ensuring our clients’ success.
Using our specialized departments and well-respected lab facility, we test a wide range of products at CPT℠. Whether you want to remove chemicals of concern, reformulate your product, meet labeling requirements or achieve a specific result within a clinical trial, examples of products that can be subjected to a HRIPT test include, but are not limited to:
Sensitive Skin is a syndrome defined by the occurrence of unpleasant sensations in response to stimuli, that would normally not provoke such a response in the general population. Those sensations can be stinging, burning, pain, tingling or other sensations. Sensitive skin can appear normal, or be accompanied by erythema, and can affect all parts of the body. Symptoms may occur as quickly as one hour when exposed to the triggering stimuli, and may persist for minutes, or even hours, but are not caused by any skin disease.
A Repeated Insult Patch Test using subjects who have self-perceived sensitive skin (SPSS), can be used to identify products which trigger the sensations noted above. With CPT SPSS Verify℠ each subject must complete a questionnaire developed specifically to qualify the subject for this test. This qualification process is documented each time that the subject participates in a SPSS RIPT. This questionnaire is an assessment tool to identify those subjects which are presently sensitive to different types of stimuli such as soaps, cosmetic products, jewelry, environmental conditions etc., so that they are screened properly to participate.
RIPTs using self-perceived sensitive skin subjects can be generated using 50, 100 or 200 subjects, depending upon the client’s criteria for their product’s risk assessment. These panels can also be used in support of attaining the National Eczema Association’s Seal of Acceptance.
CPT℠ has continually improved our custom made proprietary patches to provide the lowest possible chance of non-product related reactions that one can get with off-the-shelf patches. Clients appreciate and benefit from the additional level of research and care that CPT℠ takes in our commitment to safety of our panelists. This is why CPT℠ is the worldwide leader in Human Repeated Insult Patch Testing.
For more than 45 years, CPT℠ has been providing HRIPT testing to clients around the world. With the largest HRIPT facility in the world, we have the capability to get your product on test quickly and with the highest level of expertise.
Corporate Headquarters and Labs
70 New Dutch Ln
Fairfield, NJ 07004
973-576-5957
Satellite Clinical Lab Location
304 Wootton St.
Boonton, NJ 07005
FDA
Registration FEI # 1000151293 as a GMP/GLP/GCP Drug Establishment and Cosmetic Facility.
DEA
Registration# RC0199744 (Analytical Lab)
Schedule I-V license
Remember, Schedules I-II require DEA Form 222
Registration# RC0171568 (Researcher)
US EPA/NJ DEP
Registration# NJD982726648
ISO/IEC 17025:2017 Accreditation # 80071
